Geode Capital Management
DWTX

Geode Capital Management’s Dogwood Therapeutics DWTX Stock Holding History

Geode Capital Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
88,298
+8,864
+11% +$14.7K ﹤0.01% 4020
2026
Q1 		$168K Buy
79,434
+62,655
+373% +$184K ﹤0.01% 3978
2025
Q4 		$69.8K Buy
16,779
+1,695
+11% +$9.98K ﹤0.01% 4172
2025
Q3 		$116K Buy
15,084
+2,261
+18% +$11.3K ﹤0.01% 4090
2025
Q2 		$61.9K Sell
12,823
-1,586
-11% -$7.67K ﹤0.01% 4168
2025
Q1 		$72.2K Buy
14,409
+3,476
+32% +$23.5K ﹤0.01% 4113
2024
Q4 		$27.1K Buy
10,933
+1,703
+18% +$5.64K ﹤0.01% 4343
2024
Q3 		$39.2K Buy
9,230
+2,251
+32% +$11.7K ﹤0.01% 4309
2024
Q2 		$37.5K Hold
6,979
– – ﹤0.01% 4337
2024
Q1 		$83.6K Hold
6,979
– – ﹤0.01% 4216
2023
Q4 		$100K Hold
6,979
– – ﹤0.01% 4186
2023
Q3 		$161K Buy
6,979
+1,088
+18% +$37.8K ﹤0.01% 4063
2023
Q2 		$203K Buy
5,891
+3,480
+144% +$99.3K ﹤0.01% 4035
2023
Q1 		$22.2K Hold
2,411
– – ﹤0.01% 4687
2022
Q4 		$14K Hold
2,411
– – ﹤0.01% 4810
2022
Q3 		$22K Buy
2,411
+1,116
+86% +$157K ﹤0.01% 4904
2022
Q2 		$136K Buy
1,295
+31
+2% +$3.24K ﹤0.01% 4455
2022
Q1 		$141K Buy
1,264
+361
+40% +$52.5K ﹤0.01% 4525
2021
Q4 		$115K Buy
903
+86
+11% +$10.9K ﹤0.01% 4685
2021
Q3 		$108K Buy
817
+77
+10% +$10.7K ﹤0.01% 4652
2021
Q2 		$116K Buy
+740
New +$105K ﹤0.01% 4518

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management's DWTX Position: Q2 2026 in Review

Geode Capital Management increased its Dogwood Therapeutics (DWTX) stake by 11% in Q2 2026, buying an estimated $14.7K and bringing the position to 88,298 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

Geode Capital Management first reported a position in DWTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $203K in Q2 2023. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Geode Capital Management held 88,298 shares of Dogwood Therapeutics worth $142K as of Q2 2026.
  • Geode Capital Management bought 8,864 Dogwood Therapeutics shares in Q2 2026, an estimated $14.7K.
  • Dogwood Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4020 holding.
  • Geode Capital Management first reported a position in Dogwood Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Dogwood Therapeutics position peaked at $203K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.